Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDActual EPS
Sagimet Biosciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2025 | 4 | -$0.90 | -$0.63 | -$0.77 |
| Q2 2025 | 2 | -$0.93 | -$0.93 | -$0.93 |
| Q3 2025 | 2 | -$1.00 | -$1.00 | -$1.00 |
| Q4 2025 | 3 | -$1.00 | -$1.00 | -$1.00 |
| Q1 2026 | 2 | -$0.99 | -$0.99 | -$0.99 |
| Q2 2026 | 1 | -$0.98 | -$0.98 | -$0.98 |
| Q3 2026 | 1 | -$1.01 | -$1.01 | -$1.01 |
| Q4 2026 | 2 | -$1.05 | -$1.05 | -$1.05 |
Sagimet Biosciences Inc. Earnings Date And Information
Sagimet Biosciences Inc. last posted its earnings results on Wednesday, March 12th, 2025. The company reported $-0.5 earnings per share for the quarter, topping analysts' consensus estimates of $-0.65 by $0.15. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Sagimet Biosciences Inc. has generated $-1 earnings per share over the last year ($-1.45 diluted earnings per share) and currently has a price-to-earnings ratio of -1.63. Sagimet Biosciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 15th, 2025 based on prior year's report dates.
Sagimet Biosciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 03/12/2025 | Q4 2024 | -$0.65 | -$0.50 | 0.15 | $0 | $0 |
| 11/14/2024 | Q3 2024 | -$0.47 | -$0.45 | 0.02 | $0 | $0 |
| 08/14/2024 | Q2 2024 | -$0.34 | -$0.25 | 0.09 | $0 | $0 |
| 05/15/2024 | Q1 2024 | -$0.41 | -$0.23 | 0.18 | N/A | $0 |
| 03/25/2024 | Q4 2023 | -$0.58 | -$0.45 | 0.13 | N/A | $0 |
| 09/29/2023 | Q3 2023 | N/A | -$0.35 | N/A | N/A | $2.00 M |
| 06/29/2023 | Q2 2023 | N/A | -$0.31 | N/A | N/A | $0 |
| 03/30/2023 | Q1 2023 | N/A | -$0.30 | N/A | N/A | $0 |
| 12/30/2022 | Q4 2022 | N/A | -$0.32 | N/A | N/A | $0 |
| 09/29/2022 | Q3 2022 | N/A | -$0.34 | N/A | N/A | $0 |
| 06/29/2022 | Q2 2022 | N/A | -$0.32 | N/A | N/A | $0 |
| 03/30/2022 | Q1 2022 | N/A | -$0.39 | N/A | N/A | $0 |
| 03/30/2021 | Q1 2021 | N/A | -$0.25 | N/A | N/A | $0 |
| 03/30/2020 | Q1 2020 | N/A | -$0.18 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Sagimet Biosciences Inc. Earnings: FAQ's
Sagimet Biosciences Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 15th, 2025 based offlast year's report dates.
In the previous quarter, Sagimet Biosciences Inc. (:SGMT) reported $-0.5 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.65 by $0.15.
The conference call for Sagimet Biosciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for Sagimet Biosciences Inc.'s latest earnings report can be read online.
Sagimet Biosciences Inc. (:SGMT) has a recorded net income of $-45,567,000.Sagimet Biosciences Inc. has generated $-1.45 earnings per share over the last four quarters.
Sagimet Biosciences Inc. (:SGMT) has a price-to-earnings ratio of -1.63 and price/earnings-to-growth ratio is 0.45.